Lynx, a leading fintech platform simplifying healthcare payments and administration, today announced the close of an oversubscribed $27 million Series A funding round, bringing its total funding to over $44 million since its inception in 2022. The round was led by Flare Capital Partners, with participation from CVS Health Ventures, McKesson Ventures, and existing investors .406 Ventures, Obvious Ventures, and Frist Cressey Ventures.

Lynx is an API-first fintech platform revolutionizing healthcare payments. It enables health plans, financial institutions, and benefits administrators to embed a comprehensive suite of healthcare financial accounts and services into their existing user experiences. With a focus on innovation, scalability, and seamless integration, Lynx is redefining how healthcare payments are managed.